Search - tctmd.com

Displaying 901 - 920 of 1302

Sort: Relevancy | Date

Presentation

Clinical Outcomes and Surrogate Efficacy Data for a Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells in Patients with Ischemic or Nonischemic Chronic Heart Failure

Presenter: Emerson C. Perin

January 27, 2013

News Industry News

Updated ‘STICH’ study concludes that Surgical Ventricular Reconstruction (SVR) in conjunction with CABG decreased mortality by 64% in heart failure patients compared with CABG

January 27, 2013

News Conference News Cell Therapy 2013

Small Heart Failure Studies Show Positive Trends for Cell Therapy

January 27, 2013

Presentation Cell Therapy 2013

Clinical Trials for Non-Ischemic Cardiomyopathy: Rationale and Study Design

Presenter: Leslie Miller

January 24, 2013

Presentation Cell Therapy 2013

Cell Therapy of Acute Ischemic Stroke

Presenter: David C. Hess

January 24, 2013

News Daily News

Registry: Contralateral Occlusion Poses No Risk for Elective CAS

Caitlin E. Cox

January 24, 2013

News Daily News

Meta-Analysis Finds No Clear Answer for Same-Day Discharge After PCI

Caitlin E. Cox

January 24, 2013

Presentation Cell Therapy 2013

Myocardial Microtissue Injection in Chronic Ischemic Disease

Presenter: Steven A.J. Chamuleau

January 23, 2013

Presentation Cell Therapy 2013

Imaging of Myocardial Deformation and Electro-mechanical Activation Following Ischemic Injury

Presenter: Elisa Konofagou

January 23, 2013

Presentation Cell Therapy 2013

Growth Factor Mediated Endogenous Cardiac Repair in the Chronic Ischemic Heart.

Presenter: Stefan Koudstaal

January 23, 2013

Presentation Cell Therapy 2013

MPC's for Ischemic and Nonischemic Heart Failure

Presenter: Emerson C. Perin

January 22, 2013

Presentation Cell Therapy 2013

Clinical Outcomes and Surrogate Efficacy Data for a Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells (Revascor™) in Patients With Chronic Heart Failure of Ischemic or Nonischem

Presenter: Kenneth M. Borow

January 22, 2013

Presentation Cell Therapy 2013

CD-34+ Cells for Ischemic Heart Failure

Presenter: Bojan Vrtovec

January 22, 2013

Presentation Cell Therapy 2013

Adipose-Derived Regenerative Cells in Chronic Ischemic Heart Disease

Presenter: Emerson C. Perin

January 22, 2013

News Daily News

Ideal Duration of Dual Antiplatelet Therapy May Depend on Stent Type

Jason Kahn

January 22, 2013

News Industry News

St. Jude Medical Receives CE Mark of Next-Generation Cardiac Device for Stroke Prevention

January 17, 2013

News Daily News

Prasugrel Reloading Feasible After Clopidogrel Pretreatment in ACS Patients

Yael L. Maxwell

January 13, 2013

News Daily News

Novel Anti-inflammatory May Reduce Restenosis After BMS in High-Risk Patients

L.A. McKeown

January 13, 2013

News Daily News

Mayor Índice de Hemorragias Benignas con las Trombectomías contra los ACV Agudos

Jason Kahn

January 13, 2013

News Daily News

Higher Rate of Benign Hemorrhage Seen with Thrombectomy for Acute Stroke

Jason Kahn

January 13, 2013

Advertisement

Clinical Outcomes and Surrogate Efficacy Data for a Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells in Patients with Ischemic or Nonischemic Chronic Heart Failure

Updated ‘STICH’ study concludes that Surgical Ventricular Reconstruction (SVR) in conjunction with CABG decreased mortality by 64% in heart failure patients compared with CABG

Small Heart Failure Studies Show Positive Trends for Cell Therapy

Clinical Trials for Non-Ischemic Cardiomyopathy: Rationale and Study Design

Cell Therapy of Acute Ischemic Stroke

Registry: Contralateral Occlusion Poses No Risk for Elective CAS

Meta-Analysis Finds No Clear Answer for Same-Day Discharge After PCI

Myocardial Microtissue Injection in Chronic Ischemic Disease

Imaging of Myocardial Deformation and Electro-mechanical Activation Following Ischemic Injury

Growth Factor Mediated Endogenous Cardiac Repair in the Chronic Ischemic Heart.

MPC's for Ischemic and Nonischemic Heart Failure

Clinical Outcomes and Surrogate Efficacy Data for a Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells (Revascor™) in Patients With Chronic Heart Failure of Ischemic or Nonischem

CD-34+ Cells for Ischemic Heart Failure

Adipose-Derived Regenerative Cells in Chronic Ischemic Heart Disease

Ideal Duration of Dual Antiplatelet Therapy May Depend on Stent Type

St. Jude Medical Receives CE Mark of Next-Generation Cardiac Device for Stroke Prevention

Prasugrel Reloading Feasible After Clopidogrel Pretreatment in ACS Patients

Novel Anti-inflammatory May Reduce Restenosis After BMS in High-Risk Patients

Mayor Índice de Hemorragias Benignas con las Trombectomías contra los ACV Agudos

Higher Rate of Benign Hemorrhage Seen with Thrombectomy for Acute Stroke

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content